Institut Necker Enfants Malades
5
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 5 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (5)
Renal and Vascular Phenotypic Characterization of Patients With Enamel Renal Syndrome Due to a Pathogenic Variant of the FAM20A Gene and Pathophysiological Study of Ectopic Calcifications
Role: collaborator
Brain Involvement in Dystrophinopathies Part 2
Role: collaborator
Brain Involvement in Dystrophinopathies Part 1
Role: collaborator
Direct Oral Anticoagulant Management for Cardiac Device Implantation
Role: lead
Genetic Susceptibility to Rheumatic Heart Disease in the Pacific Region
Role: collaborator
All 5 trials loaded